Adagene Inc. ADAG
- muzastotug — Colorectal Cancer Phase 2
- ADG126 — Hepatocellular Carcinoma Phase 1
- ADG116 Phase 1
CTLA-4 (4 companies · 8 programs)
Companies with an active program directed at CTLA-4.
Replimune Group, Inc. REPL
- sturlimgene erparepvec — Uveal Melanoma Phase 2
- sturlimgene erparepvec — Hepatocellular Carcinoma Phase 2
- sturlimgene erparepvec — Biliary Tract Cancer Phase 2
BriaCell Therapeutics Corp. BCTX
- Soluble CD80 Preclinical
Zenas BioPharma, Inc. ZBIO
- ZB004